Remove tag behaviour-change
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Nevertheless, the advent of COVID-19 is forcing pharma, and many other sectors, to make some radical changes.

article thumbnail

Actualising the power of antibody-drug conjugates as cancer therapeutics

European Pharmaceutical Review

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. tag ® , inspired by the unique features of microtubule biology and perfectly suited for DAR 2 and DAR 4 ADCs. cancer agent or disease-relevant toxin.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. The covid vaccine roll out is arguably the best example of why communications, and specifically behavioural science as part of that, plays such a pivotal role in healthcare.”. Pfizer is understood to have charged $19.50 per dose in the US and €19.50

Vaccines 137
article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). The requirement for complex medicines to be fluorescently labelled is another limitation of the method – labelling can be a complicated process, and there is a risk that it could change the behaviour of the compounds.